Home / Stocks / Bajaj Healthcare Limited
BAJAJHCARE

Bajaj Healthcare Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹318.5

Change

-1.75 (-0.55%)

Open

₹320.5

Prev. Close

₹320.25

Day High

₹320.5

Day Low

₹315.15

Volume Analysis

Traded

35,421

Delivered

18,412

Delivery %

51.98%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (1)

  • •Promoter holding is falling

Opportunities (1)

  • •FII holding has been rising

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹326.3 ₹323.4 ₹320.95 ₹318.05 ₹315.6 ₹312.7 ₹310.25
Fibonacci ₹323.4 ₹321.36 ₹320.09 ₹318.05 ₹316.01 ₹314.74 ₹312.7
Camarilla ₹319.97 ₹319.48 ₹318.99 ₹318.05 ₹318.01 ₹317.52 ₹317.03

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-25.0%

1 Week

-2.11%

1 Month

-2.14%

3 Months

-1.09%

6 Months

+4.24%

1 Year

-26.05%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

2.86%

Net margin 2.62% × asset turnover 0.62x × equity multiplier 1.76x

Company Overview

Sector

Healthcare

Source: Screener.in (Consolidated figures) — data as of 18 Nov 2026. Not investment advice.

TopFund Analysis

Bajaj Healthcare Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 51/100. The strongest factor is Financial Strength (88/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is falling. FII holding has been rising.

TopFund Score — Fundamentals Quality

51/100 — Average

Data confidence: 74/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

88

Growth

0

Cash Flow

47

Corporate Governance

76

Institutional Ownership

53

Business Quality

60

Risk & Volatility

37

Liquidity

33

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Intimation for allotment of 26,710 Equity Shares pursuant to exercise of ESOPs

Audio recording of Q2 and H1 FY27 earnings call uploaded on company website.

Bajaj Healthcare Q2 FY27 PAT rose 26.9% to Rs.14.1 crore; Cenobamate approval, GenRx acquisition approval reported.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 (S) Dec 2023 (S) Mar 2024 (S) Jun 2024 (S) Sep 2024 (S) Dec 2024 (S) Mar 2025 (S) Jun 2025 (S) Sep 2025 (S) Dec 2025 (S) Mar 2026 (S) Jun 2026 (S) Sep 2026 (S)
Sales + 101 109 134 132 133 123 154 149 148 161 153 166 176
Expenses + 82 89 118 108 109 101 143 124 121 131 130 137 145
Operating Profit 19 20 16 24 25 22 12 25 27 31 23 29 31
OPM % 19.0% 18.0% 12.0% 19.0% 18.0% 18.0% 8.0% 16.0% 18.0% 19.0% 15.0% 17.0% 18.0%
Other Income + -7 -7 -36 0 4 -1 13 1 0 1 -34 1 1
Interest 8 7 6 8 8 6 6 5 6 6 6 6 6
Depreciation 7 7 7 7 7 7 8 6 7 7 8 7 8
Profit before tax -3 -1 -33 9 14 8 11 14 15 19 -24 16 18
Tax % 4.0% 58.0% -10.0% 23.0% 30.0% -39.0% 1.0% 17.0% 24.0% 17.0% -6.0% 16.0% 23.0%
Net Profit + -3 -2 -30 7 9 12 11 12 11 16 -23 14 14
EPS in Rs -1 -1 -11 3 3 4 4 4 4 5 -7 4 4
Raw PDF — — — — — — — — — — — — —
YoY Sales growth -48 -18 -13 2 32 13 15 13 11 31 -1 11 19

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Sales + 218 223 231 327 370 410 657 680 646 473 543 611
Expenses + 189 193 200 288 327 362 521 561 534 397 460 506
Operating Profit 29 30 31 39 43 48 136 119 112 76 83 105
OPM % 13.0% 14.0% 13.0% 12.0% 12.0% 12.0% 21.0% 17.0% 17.0% 16.0% 15.0% 17.0%
Other Income + 0 0 2 2 1 7 7 1 -19 -105 16 -32
Interest 8 8 8 8 8 7 8 13 18 30 28 22
Depreciation 9 9 11 11 11 12 16 18 17 28 28 28
Profit before tax 12 14 14 23 24 36 119 90 58 -86 43 23
Tax % 37.0% 39.0% 43.0% 33.0% 33.0% 30.0% 30.0% 20.0% 25.0% -3.0% 7.0% 33.0%
Net Profit + 8 8 8 15 16 25 83 71 43 -84 40 16
EPS in Rs 3 3 3 6 6 9 30 26 16 -30 13 5
Dividend Payout % 0.0% 0.0% 0.0% 5.0% 0.0% 0.0% 5.0% 6.0% 6.0% -3.0% 8.0% 32.0%
Sales growth 7 2 4 42 13 11 60 3 -5 -27 15 13

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S) Sep 2026 (S)
Reserves 78 82 92 107 122 164 245 315 354 265 450 516 540
Borrowings + 70 81 75 87 81 91 181 257 415 333 223 249 282
Other Liabilities + 38 39 45 68 57 74 86 136 115 154 144 141 142
Total Liabilities 189 209 219 268 267 343 526 721 898 765 833 923 981
Fixed Assets + 108 130 128 127 128 162 208 270 366 253 238 248 263
CWIP 1 1 0 2 1 5 57 52 22 7 3 8 11
Investments 0 0 0 0 0 5 0 0 0 0 0 0 0
Other Assets + 79 78 91 140 137 170 260 399 510 506 591 667 708
Total Assets 189 209 219 268 267 343 526 721 898 765 833 923 981
Equity Capital 2 7 7 7 7 14 14 14 14 14 16 17 17

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Cash from Operating Activity + 28 25 22 17 25 21 44 1 -22 92 22 58
Cash from Investing Activity + -17 -31 -8 -12 -13 -28 -109 -75 -93 -11 -15 -48
Cash from Financing Activity + -11 5 -13 2 -13 3 75 62 131 -97 -6 24
Net Cash Flow 0 0 0 7 0 -4 10 -12 16 -16 0 35
Free Cash Flow 11 -6 14 5 11 -2 -70 -74 -115 73 10 18
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 99 100 88 57 89 62 58 9 -10 138 32 53

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 67.73% → 58.58%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 31.06% 31.31% 32.27% 37.77% 37.45% 37.25% 36.56% 36.7% 36.67% 36.82% 37.3% 37.36%
Promoters 67.73% 67.74% 67.74% 59.19% 59.19% 59.19% 59.19% 59.19% 59.19% 58.29% 58.59% 58.58%
FII 0.74% 0.53% 0.0% 1.07% 1.01% 1.05% 1.09% 1.12% 1.18% 1.98% 2.19% 2.09%
DII 0.48% 0.43% 0.0% 1.97% 2.36% 2.52% 3.16% 2.99% 2.96% 2.91% 1.92% 1.96%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Bajaj Healthcare Limited (this stock) — — — —
Sun Pharmaceutical Ind L 451,075 36.7 5.05 16.0%
Divi S Laboratories Ltd 294,139 86.1 16.34 16.5%
Torrent Pharmaceuticals L 177,632 81.8 9.67 27.4%
Apollo Hospitals Enter. L 125,893 55.6 11.86 21.5%
Laurus Labs Limited 125,380 93.6 20.73 18.3%
Zydus Lifesciences Ltd 118,693 26.2 4.27 21.2%

Which Mutual Funds Hold Bajaj Healthcare Limited?

Frequently Asked Questions about Bajaj Healthcare Limited

Community Sentiment

What are other investors saying about Bajaj Healthcare Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.